Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Aug 9:4:865-9.
doi: 10.2147/opth.s12869.

The controversy over the association between statins use and progression of age-related macular degeneration: a mini review

Vasileios Peponis  1 , Spyridon E Chalkiadakis, Stefanos Bonovas, Nikolaos M Sitaras
Affiliations

The controversy over the association between statins use and progression of age-related macular degeneration: a mini review

Vasileios Peponis et al. Clin Ophthalmol. .

Abstract

Objective: Age-related macular degeneration (AMD) is the leading cause of blindness in western societies. Statins comprise a class of pharmacological agents that reduce plasma cholesterol levels, and have been shown to prevent progression of atherosclerosis and reduce cardiovascular mortality. The relationship between these medications and AMD has been evaluated in several recent studies. Herein, we examine the current evidence for an association between statin use and risk of AMD.

Methods: Literature database search (Medline, Scopus, and Science Citation Index Expanded) for articles published up to March 2010, using particular search terms.

Results: From the current evidence available, it is not safe to conclude upon the assumption of a protective effect of statins against age-related maculopathy and AMD.

Conclusion: There is a need for large scale prospective studies with a long follow-up period and accurate assessment of AMD to further explore this matter.

Keywords: age-related macular degeneration (AMD); blindness; controversy; statin use.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Congdon NG, Friedman DS, Lietman T. Important causes of visual impairment in the world today. JAMA. 2003;290:2057–2060. - PubMed
    1. Fine SL, Maguire MG. It is not time to abandon radiotherapy for neovascular age-related macular degeneration. Arch Ophthalmol. 2001;119:275–276. - PubMed
    1. Fine SL, Berger JW, Maguire MG, Ho AC. Age-related macular degeneration. N Engl J Med. 2000;342:483–492. - PubMed
    1. Friedman E. The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration. Am J Ophthalmol. 2000;130:658–663. - PubMed
    1. Friedman E. A hemodynamic model of the pathogenesis of age-related macular degeneration. Am J Ophthalmol. 1997;124:677–682. - PubMed

LinkOut - more resources